LA
XAGEW

Linden Advisors’s Longevity Health Holdings, Inc. Warrant XAGEW Stock Holding History

Linden Advisors’s Portfolio XAGEW Stock Details XAGEW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-371,248
Closed -$9.95K – 431
2025
Q2 		$9.95K Hold
371,248
– – ﹤0.01% 367
2025
Q1 		$13.4K Hold
371,248
– – ﹤0.01% 289
2024
Q4 		$20.9K Hold
371,248
– – ﹤0.01% 232
2024
Q3 		$32.5K Hold
371,248
– – ﹤0.01% 210
2024
Q2 		$26.9K Hold
371,248
– – ﹤0.01% 234
2024
Q1 		$64.9K Hold
371,248
– – ﹤0.01% 223
2023
Q4 		$81.3K Hold
371,248
– – ﹤0.01% 222
2023
Q3 		$93.3K Hold
371,248
– – ﹤0.01% 245
2023
Q2 		$65K Hold
371,248
– – ﹤0.01% 258
2023
Q1 		$63.1K Hold
371,248
– – ﹤0.01% 306
2022
Q4 		$55K Hold
371,248
– – ﹤0.01% 405
2022
Q3 		$109K Hold
371,248
– – ﹤0.01% 483
2022
Q2 		$141K Hold
371,248
– – ﹤0.01% 512
2022
Q1 		$290K Buy
+371,248
New +$282K ﹤0.01% 522

Other funds holding XAGEW

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Linden Advisors's XAGEW Position: Q3 2025 in Review

Linden Advisors sold out of Longevity Health Holdings, Inc. Warrant (XAGEW) in Q3 2025, closing a stake of 371,248 shares — an estimated $9.95K sold.

Linden Advisors first reported a position in XAGEW in Q1 2022 and held it in 14 quarters. The position peaked at $290K in Q1 2022. 1 fund tracked by Wall St. Rank holds XAGEW as of Q3 2025.

  • Linden Advisors reported no remaining Longevity Health Holdings, Inc. Warrant position as of Q3 2025 after selling out during the quarter.
  • Linden Advisors sold 371,248 Longevity Health Holdings, Inc. Warrant shares in Q3 2025, an estimated $9.95K.
  • Linden Advisors first reported a position in Longevity Health Holdings, Inc. Warrant in Q1 2022 and held it in 14 quarters.
  • Linden Advisors's Longevity Health Holdings, Inc. Warrant position peaked at $290K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Longevity Health Holdings, Inc. Warrant as of Q3 2025.

Based on Linden Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.